BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
Abstract Bruton’s tyrosine kinase (BTK) is an essential component of multiple signaling pathways that regulate B cell and myeloid cell proliferation, survival, and functions, making it a promising therapeutic target for various B cell malignancies and inflammatory diseases. Five small molecule inhib...
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
BMC
2022-10-01
|
| سلاسل: | Journal of Hematology & Oncology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s13045-022-01353-w |